Renal Biomarkers Market Report by Biomarker Type, Diagnostic Technique, End User, and Region 2024-2032

The global renal biomarkers market size reached US$ 1.3 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2023-2032.

Renal biomarkers are cells, proteins, lipids, microRNAs, genes, metabolites, or proteomic patterns present on a urinalysis. They assist in determining the glomerular filtration rate (GFR) of kidneys to analyze their proper functioning and evaluating pathogenic processes or pharmacological responses to therapeutic interventions. As they also aid in predicting disease progression and computing drug dosage, renal biomarkers find extensive applications in hospitals and diagnostic laboratories across the globe.

Renal Biomarkers Market Trends:

Chronic kidney disease (CKD), non-communicable disease with considerable morbidity and mortality, has gradually become a public health concern globally and its main risk factors are diabetes, hypertension and heart diseases. The increasing number of individuals with CKD represents one of the key factors propelling the growth of the market. Moreover, renal biomarkers, including blood urea nitrogen (BUN), serum creatinine (SCr), urinary albumin/protein and volume excretion, are used in the diagnosis of chronic kidney disease (CKD) and monitoring of the disease. Besides this, there is a growing interest of industry investors in novel single biomarkers and process-specific biomarker panels in human renal diseases around the world. These novel biomarkers provide vital diagnostic and prognostic information and help predict response to the treatment of glomerulopathies, acute kidney injury (AKI), and autosomal dominant polycystic kidney disease (ADPKD). Apart from this, renal biomarkers are becoming accessible and feasible in all-sized laboratories. This, along with the development and integration of genomics, epigenetics, transcriptomics, proteomics, and metabolomics, is positively influencing the market. Some of the other factors, such as the burgeoning healthcare industry, the rising geriatric population, and the increasing number of clinical trials for CKD worldwide, are anticipated to facilitate the growth of the market.

Key Market Segmentation:

The report provides an analysis of the key trends in each sub-segment of the global renal biomarkers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on biomarker type, diagnostic technique and end user.

Breakup by Biomarker Type:

Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-regulated Protein
Neutrophil Gelatinase-Associated Lipocalin (NGAL)
Kidney Injury Molecule-1
INTERLEUKIN-18
Others

Breakup by Diagnostic Technique:

Enzyme-linked Immunosorbent Assay (ELISA)
Particle-enhanced Turbidimetric Immunoassay (PETIA)
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay (CLIA)
Liquid Chromatography Mass Spectrometry (LC-MS)

Breakup by End User:

Hospital
Diagnostic Laboratory
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), bioMérieux SA, BioPorto A/S, Bio-Rad Laboratories Inc., Enzo Biochem Inc., F. Hoffmann-La Roche AG, PerkinElmer Inc., Randox Laboratories Ltd., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1. What was the size of the global renal biomarkers market in 2023?
2. What is the expected growth rate of the global renal biomarkers market during 2024-2032?
3. What has been the impact of COVID-19 on the global renal biomarkers market?
4. What are the key factors driving the global renal biomarkers market?
5. What is the breakup of the global renal biomarkers market based on the biomarker type?
6. What is the breakup of the global renal biomarkers market based on the diagnostic technique?
7. What is the breakup of the global renal biomarkers market based on end user?
8. What are the key regions in the global renal biomarkers market?
9. Who are the key players/companies in the global renal biomarkers market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Renal Biomarkers Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Biomarker Type

6.1 Functional Biomarker
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Serum Creatinine
6.1.2.2 Serum Cystatin C
6.1.2.3 Urine Albumin
6.1.3 Market Forecast
6.2 Up-regulated Protein
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Neutrophil Gelatinase-Associated Lipocalin (NGAL)
6.2.2.2 Kidney Injury Molecule-1
6.2.2.3 INTERLEUKIN-18
6.2.3 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Diagnostic Technique

7.1 Enzyme-linked Immunosorbent Assay (ELISA)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Particle-enhanced Turbidimetric Immunoassay (PETIA)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Colorimetric Assay
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Chemiluminescent Immunoassay (CLIA)
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Liquid Chromatography Mass Spectrometry (LC-MS)
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by End User

8.1 Hospital
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Diagnostic Laboratory
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Beckman Coulter Inc. (Danaher Corporation)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 bioMérieux SA
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 BioPorto A/S
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Bio-Rad Laboratories Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Enzo Biochem Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 F. Hoffmann-La Roche AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 PerkinElmer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Randox Laboratories Ltd.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Siemens AG
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Thermo Fisher Scientific Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: Renal Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Renal Biomarkers Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Renal Biomarkers Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Renal Biomarkers Market: Breakup by Biomarker Type (in %), 2023
Figure 5: Global: Renal Biomarkers Market: Breakup by Diagnostic Technique (in %), 2023
Figure 6: Global: Renal Biomarkers Market: Breakup by End User (in %), 2023
Figure 7: Global: Renal Biomarkers Market: Breakup by Region (in %), 2023
Figure 8: Global: Renal Biomarkers (Functional Biomarker) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Renal Biomarkers (Functional Biomarker) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Renal Biomarkers (Up-regulated Protein) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Renal Biomarkers (Up-regulated Protein) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Renal Biomarkers (Other Biomarker Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Renal Biomarkers (Other Biomarker Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Renal Biomarkers (Enzyme-linked Immunosorbent Assay (ELISA)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Renal Biomarkers (Enzyme-linked Immunosorbent Assay (ELISA)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Renal Biomarkers (Particle-enhanced Turbidimetric Immunoassay (PETIA)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Renal Biomarkers (Particle-enhanced Turbidimetric Immunoassay (PETIA)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Renal Biomarkers (Colorimetric Assay) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Renal Biomarkers (Colorimetric Assay) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Renal Biomarkers (Chemiluminescent Immunoassay (CLIA)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Renal Biomarkers (Chemiluminescent Immunoassay (CLIA)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Renal Biomarkers (Liquid Chromatography Mass Spectrometry (LC-MS)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Renal Biomarkers (Liquid Chromatography Mass Spectrometry (LC-MS)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Renal Biomarkers (Hospital) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Renal Biomarkers (Hospital) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Renal Biomarkers (Diagnostic Laboratory) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Renal Biomarkers (Diagnostic Laboratory) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Renal Biomarkers (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Renal Biomarkers (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: North America: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: North America: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: United States: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: United States: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Canada: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Canada: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Asia-Pacific: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Asia-Pacific: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: China: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: China: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Japan: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Japan: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: India: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: India: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: South Korea: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: South Korea: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Australia: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Australia: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Indonesia: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Indonesia: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Others: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Others: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Europe: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Europe: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Germany: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Germany: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: France: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: France: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: United Kingdom: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: United Kingdom: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Italy: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Italy: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Spain: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Spain: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Russia: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Russia: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Others: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Others: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Latin America: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Latin America: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Brazil: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Brazil: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Mexico: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Mexico: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Others: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Others: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Middle East and Africa: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Middle East and Africa: Renal Biomarkers Market: Breakup by Country (in %), 2023
Figure 78: Middle East and Africa: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Global: Renal Biomarkers Industry: SWOT Analysis
Figure 80: Global: Renal Biomarkers Industry: Value Chain Analysis
Figure 81: Global: Renal Biomarkers Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Renal Biomarkers Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Renal Biomarkers Market Forecast: Breakup by Biomarker Type (in Million US$), 2024-2032
Table 3: Global: Renal Biomarkers Market Forecast: Breakup by Diagnostic Technique (in Million US$), 2024-2032
Table 4: Global: Renal Biomarkers Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Renal Biomarkers Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Renal Biomarkers Market: Competitive Structure
Table 7: Global: Renal Biomarkers Market: Key Players

Companies Mentioned

Abbott Laboratories
Beckman Coulter Inc. (Danaher Corporation)
bioMérieux SA
BioPorto A/S
Bio-Rad Laboratories Inc.
Enzo Biochem Inc.
F. Hoffmann-La Roche AG
PerkinElmer Inc.
Randox Laboratories Ltd.
Siemens AG
Thermo Fisher Scientific Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	135
Published	July 2024
Forecast Period	2023 - 2032
Estimated Market Value ( USD ) in 2023	$ 1.3 Billion
Forecasted Market Value ( USD ) by 2032	$ 2.5 Billion
Compound Annual Growth Rate	7.5%
Regions Covered	Global
No. of Companies Mentioned	11

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3812EUR$3,899USD£3,184GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€4789EUR$4,899USD£4,000GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5767EUR$5,899USD£4,817GBP

Renal Biomarkers Market Trends:

Key Market Segmentation:

Breakup by Biomarker Type:

Breakup by Diagnostic Technique:

Breakup by End User:

Breakup by Region:

Competitive Landscape:

Key Questions Answered in This Report

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Renal Biomarkers Market by Marker Type, Assay Platform Type, Application, End-User - Global Forecast 2025-2030

Renal Biomarkers - Global Strategic Business Report

Renal Biomarkers Global Market Report 2024

Renal Biomarkers - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

2024 Global Forecast for Renal Biomarkers Market (2025-2030 Outlook)-High Tech & Emerging Markets Report